Received Aug 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | IM |
Shingrix vaccination given in a gluteus muscle; This non-serious case was reported by a nurse via call center representative and described the occurrence of vaccine administered at inappropriate site in a patient who received Herpes zoster (Shingrix) for prophylaxis. On 14-AUG-2025, the patient received Shingrix (intramuscular, unknown gluteal). On 14-AUG-2025, an unknown time after receiving Shingrix, the patient experienced vaccine administered at inappropriate site (Verbatim: Shingrix vaccination given in a gluteus muscle). The outcome of the vaccine administered at inappropriate site was not applicable. Additional Information: GSK Receipt Date: 14-AUG-2025 The supervisor of a health department reported that a Shingrix vaccination was given to a patient in a gluteus muscle, which led to vaccine administered at inappropriate site.